Apheresis Market Set to Surge to $5.3 Billion by 2031 at a 8.3% CAGR

As of 2021, the global apheresis market was valued at approximately $2.4 billion. Projections indicate that this figure will reach $5.3 billion by 2031, reflecting a CAGR of 8.3% from 2022 to 2031. Apheresis is a medical procedure that involves the extraction of whole blood from a donor or patient, separating it into individual components, retaining the desired elements, and returning the remainder to the circulation. This technique is pivotal in treating various hematological, neurological, and autoimmune disorders, as well as in blood component donation. The global apheresis market has experienced significant growth in recent years, driven by technological advancements, increased demand for blood components, and supportive government initiatives.

Read More Here: https://www.alliedmarketresearch.com/apheresis-market

Apheresis Market Growth Factors

Several factors contribute to the robust expansion of the apheresis market:

1. Rising Demand for Blood Components: The increasing prevalence of chronic diseases and the need for blood transfusions have escalated the demand for specific blood components, such as plasma and platelets. Apheresis allows for the efficient collection of these components, thereby meeting clinical needs.

2. Technological Advancements: Innovations in apheresis devices have enhanced the safety, efficiency, and efficacy of procedures. For instance, the development of automated apheresis machines and improvements in disposable kits have streamlined operations and reduced risks.

3. Government Initiatives and Support: Many governments have implemented programs to encourage blood donation and support apheresis procedures. These initiatives include awareness campaigns, funding for blood centers, and policies to ensure the availability of blood components.

4. Expanded Therapeutic Applications: Apheresis is now utilized in treating a broader range of conditions, including autoimmune hemolytic anemia, acute disseminated encephalomyelitis, and cardiac neonatal lupus. This expansion in therapeutic indications has increased the procedure's adoption in clinical settings.

Get Sample PDF Copy: https://www.alliedmarketresearch.com/request-sample/2855

Apheresis Market Segmentation

The apheresis market is segmented based on product, method, procedure, component, end user, and region.

By Product:

- Devices: This segment includes machines used for apheresis procedures.

- Disposables & Reagents: Comprising disposable kits, tubing, and reagents necessary for each procedure, this segment was the highest contributor to the market in 2021. The trend is expected to continue due to ongoing advancements in disposable products.

- Software: Encompasses digital solutions that assist in managing apheresis procedures and data.

By Method:

- Centrifugation: Dominated the market in 2021, owing to its widespread use in separating blood components like packed red blood cells and fresh frozen plasma in a single-step heavy spin.

- Membrane Separation: Expected to witness considerable growth, as membrane filters are crucial in filtering plasma from other cellular components to achieve specific cell separation.

- Selective Adsorption: Involves the removal of specific components from the blood using adsorption techniques.

By Procedure:

- Donor/Automated Apheresis: This segment dominated the market in 2021, primarily due to the significant role of blood centers in conducting donor apheresis procedures. The increase in platelet and plasma donations has further contributed to this trend.

- Therapeutic Apheresis: Expected to experience considerable growth, driven by a rising patient base suffering from chronic disorders. Therapeutic apheresis is performed to remove disease mediators in plasma, diseased cells, excess cells, or to replace them with normal blood components.

By Component:

- Plasma (Plasmapheresis): Dominated the market in 2021, owing to its wide utilization across renal & metabolic diseases and hematologic & neurologic disorders.

- Platelets (Plateletpheresis): Anticipated to witness considerable growth due to the increasing number of platelet apheresis procedures globally.

- Leukocytes (Leukapheresis): Involves the separation and collection of white blood cells for therapeutic purposes.

- Lymphocytes (Lymphapheresis): Focuses on the removal or collection of lymphocytes, often for research or therapeutic applications.

- Red Blood Cells (Erythropheresis): Entails the separation and collection of red blood cells, typically used in treating specific hematologic conditions.

By End User:

- Blood Centers: Dominated the market in 2021, as donor apheresis forms a major constituent of the apheresis industry, with most procedures performed in these centers.

- Hospitals: Serve as significant users of apheresis procedures, especially for therapeutic purposes.

- Others: Includes academic institutions, research institutes, and biopharmaceutical manufacturers. This segment is expected to witness considerable growth, driven by the increasing demand for plasma-based drugs.

By Region:

- North America: Led the market in 2021, attributed to the early adoption of novel apheresis systems and a high prevalence of blood-related disorders.

- Europe: Holds a significant market share due to advanced healthcare infrastructure and increased awareness of apheresis procedures.

- Asia-Pacific: Projected to register the highest CAGR of 9.3% from 2021 to 2031, owing to a large population base and a surge in the geriatric population, which is more susceptible to chronic injuries and disorders.

- LAMEA (Latin America, Middle East, and Africa): Represents a smaller market share but offers potential growth opportunities with improving healthcare access and infrastructure.

Key Players in the Apheresis Market

The apheresis market features several prominent companies:

- Asahi Kasei Medical Co., Ltd.
- B. Braun Melsungen AG
- Cerus Corporation
- Fresenius Kabi
- Haemonetics Corporation
- Kaneka Corporation
- Kawasumi Laboratories, Inc.
- Medica S.p.A.
- Terumo Corporation
- Nikkiso Co., Ltd.

These companies play a crucial role in the development, manufacturing, and distribution of apheresis devices and disposables, contributing to market growth through continuous innovation and strategic partnerships.

The apheresis market is poised for substantial growth, driven by advancements in technology, increased demand for blood components, and expanding therapeutic applications. With government initiatives supporting blood donation programs and growing healthcare awareness, the adoption of apheresis procedures is expected to rise significantly.

Furthermore, increasing investments in research and development will likely lead to the introduction of more efficient and safer apheresis systems, enhancing patient outcomes. As key players continue to innovate and expand their presence, the market is expected to experience steady growth, providing improved healthcare solutions worldwide.

Procure Complete Report: https://www.alliedmarketresearch.com/checkout-final/eab03b75d7e01d042a0e4552f009db65?utm_source=Nilesh.Musale

Thanks for reading this article; you can also get an individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia.

Contact Us:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.